Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.
about
Protection against Asiatic Taenia solium induced by a recombinant 45W-4B proteinManaging neurocysticercosis: challenges and solutionsMonitoring the outcomes of interventions against Taenia solium: options and suggestionsDifferential release and phagocytosis of tegument glycoconjugates in neurocysticercosis: implications for immune evasion strategiesAnalyses of an expressed sequence tag library from Taenia solium, CysticercaCharacterization of a novel Taenia solium oncosphere antigen.Vaccines to combat the neglected tropical diseases.A novel Taenia solium protein that resembles troponin T proteins.Transcriptome analysis of Taenia solium cysticerci using Open Reading Frame ESTs (ORESTES).Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccineGenetic vaccination against murine cysticercosis by using a plasmid vector carrying Taenia solium paramyosin.Validity of the Enzyme-linked Immunoelectrotransfer Blot (EITB) for naturally acquired porcine cysticercosis.Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon.Antibody responses to the host-protective Taenia solium oncosphere protein TSOL18 in pigs are directed against conformational epitopesState of the art of Taenia solium as compared to Taenia asiatica.Use of oxfendazole to control porcine cysticercosis in a high-endemic area of Mozambique.Priorities for research and control of cestode zoonoses in Asia.Geographic correlation between tapeworm carriers and heavily infected cysticercotic pigs.Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico.Heterologous prime-boost oral immunization with GK-1 peptide from Taenia crassiceps cysticerci induces protective immunityThe highly antigenic 53/25 kDa Taenia solium protein fraction with cathepsin-L like activity is present in the oncosphere/cysticercus and induces non-protective IgG antibodies in pigsCharacterization of the carbohydrate components of Taenia solium oncosphere proteins and their role in the antigenicity.Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigensSuccessful immunization of naturally reared pigs against porcine cysticercosis with a recombinant oncosphere antigen vaccineModelling the risk of Taenia solium exposure from pork produced in western Kenya.Genes encoding homologous antigens in taeniid cestode parasites: Implications for development of recombinant vaccines produced in Escherichia coli.A review on diagnostic and preventive aspects of cystic echinococcosis and human cysticercosis.The immune response in Taenia solium cysticercosis: protection and injury.Elimination of Taenia solium Transmission in Northern Peru.Vaccination with recombinant oncosphere antigens reduces the susceptibility of sheep to infection with Taenia multiceps.Vaccine development against the Taenia solium parasite: the role of recombinant protein expression in Escherichia coli.The ultrastructure of taeniid cestode oncospheres and localization of host-protective antigens.Epilepsy and neurocysticercosis in sub-Saharan Africa.Assessing the impact of intervention strategies against Taenia solium cysticercosis using the EPICYST transmission modelBioactive molecules of Taenia solium metacestode, a causative agent of neurocysticercosis.Cysticercosis of the central nervous system: how should it be managed?Prevention and control of Taenia solium taeniasis/cysticercosis in Peru.Development of the S3Pvac vaccine against porcine Taenia solium cysticercosis: a historical review.Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities.Neurocysticercosis: A disease of neglect.
P2860
Q24652442-61009F23-0E66-471C-9712-C748CA7EAC20Q26777315-9BEC5246-B3DD-4F93-B679-DB73C88944B6Q26779984-72D4CBE3-1466-4969-88B2-AC2963DDACC7Q28472463-7A90858B-7045-43EA-B7FB-8A39186128DCQ28476587-6F1E7C3B-AC5E-4C22-8E3D-E4378CC843E4Q30364569-0C579B98-8383-4644-B7C8-B69998D6872CQ30425005-571199A1-45C1-4C88-8228-9207B3685586Q33393812-52C9F2BD-C1C3-417A-B6E3-6CDFBAD2DA0EQ33489046-95DB4941-879F-479B-9003-CB4931208F15Q33619325-F19E3670-502C-4C1F-B13B-DB53F4FFBED4Q33716181-6CE4D89D-4BD5-4E73-9F9E-2918FB7B59E6Q33739001-F0798DA0-2345-49A4-9E74-811545BCCDA7Q33799266-153B9D8D-4BB3-47A3-977E-94BB26AF298DQ33895961-34DD43C0-4A46-4A88-B26E-ABE570117813Q34035917-265C5B9B-3340-4B05-921D-702D725FBB70Q34293015-7BE1ED3A-5B9D-43A5-830C-C38D0AFB787BQ34361874-E815FC6E-D879-4EF2-B328-727EA5B77BA5Q34535304-87135270-101E-459E-834E-712147627476Q34562751-813F168D-257D-4007-9F1A-5FF6D4B453FDQ35138626-44C15BC1-98CE-4580-9524-0EA05B13DD64Q35739946-70043241-42B9-4B2F-9154-810D023FB0D7Q35749710-127C75B9-BE64-4A83-949C-310FF4EE6223Q36060914-96386248-B07B-4348-A1A6-0AF2CAEEDDF0Q36167073-35FDED0A-3BFB-4F23-8AE2-7A0BCF7CD30AQ36284108-8B26EC69-C75E-46B0-9558-DDAAD7668724Q36892009-76C34388-4167-492D-A8B2-217D85168C53Q36924299-871459D0-2FE0-453C-A23A-E9FEE6484A76Q37016245-ED712380-E85A-4F46-8437-CA2C6709949CQ37129838-05E6FB22-B1DE-41F2-8100-C57B3160F805Q37253466-31AEAC2D-09DB-4907-B128-69DF7B1821AAQ37269125-B0C07D78-7102-410A-BD64-A1C5C2FA4AE0Q37616223-5A595225-5FEF-435E-B226-147DA8A854EEQ37633387-AF728583-0477-425D-B75D-DDE57DDC461DQ37635266-294B98F7-B78E-4AB7-BE4F-87C6B82B7674Q37802871-C3578DF1-9A2F-429C-9FBA-CC6B9FD88C06Q37905499-6075B4D6-8769-4246-BFBA-8376E945D4AFQ38069638-037CE57F-A9C2-4974-B5C7-97060A1BC5B2Q38085075-69CD83D8-A840-4CD7-9608-A2AE780D5416Q38129110-B1AC9956-F6DB-4BFD-988E-BB6811386D51Q38182595-DF148BCF-DA98-482B-B1C2-DF9DB5A1FD13
P2860
Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Induction of protection agains ...... combinant oncosphere antigens.
@en
Induction of protection agains ...... combinant oncosphere antigens.
@nl
type
label
Induction of protection agains ...... combinant oncosphere antigens.
@en
Induction of protection agains ...... combinant oncosphere antigens.
@nl
prefLabel
Induction of protection agains ...... combinant oncosphere antigens.
@en
Induction of protection agains ...... combinant oncosphere antigens.
@nl
P2093
P2860
P1476
Induction of protection agains ...... combinant oncosphere antigens.
@en
P2093
Adriana Garza-Rodriguez
Ana Flisser
André Zoli
Charles G Gauci
Craig Kyngdon
Guillermina Avila
Joel Martinez-Ocaña
Jose Luis Dominguez-Alpizar
Laura Aguilar-Vega
Marshall W Lightowlers
P2860
P304
P356
10.1128/IAI.72.9.5292-5297.2004
P407
P577
2004-09-01T00:00:00Z